Association of serum galectin-3 levels with mortality and cardiovascular disease outcomes in hemodialysis patients: a systematic review and dose-response meta-analysis.
Ioannis BellosSmaragdi MarinakiPagona LagiouVassiliki BenetouPublished in: International urology and nephrology (2024)
This study suggests that high serum galectin-3 levels are associated with greater all-cause mortality risk among patients on maintenance hemodialysis. Preliminary cross-sectional evidence indicates that serum galectin-3 may be associated with arterial stiffness and left ventricular dysfunction.
Keyphrases
- cardiovascular disease
- systematic review
- cross sectional
- left ventricular
- heart failure
- oxidative stress
- cardiovascular events
- chronic kidney disease
- randomized controlled trial
- acute myocardial infarction
- risk factors
- metabolic syndrome
- acute coronary syndrome
- skeletal muscle
- aortic valve
- left atrial
- weight loss
- aortic stenosis
- glycemic control